Support The Moscow Times!

New One-Step RNA Discovery Represents Great Leap Backward

CAMBRIDGE, Massachusetts -- Moving a step closer to understanding how life began, scientists say they have produced a complex molecule similar to those that existed on earth 3 billion years ago.


Researchers at the Whitehead Institute for Biomedical Research and the Massachusetts General Hospital found that complex ribozymes -- catalytic molecules made of ribonucleic acid, or RNA, which promote chemical reactions -- could have originated in one step rather than evolving over time.


"We're trying to understand how life arose on earth. The experiments provide a little more evidence that helps us understand the origin of life," said Jack Szostak, a molecular biologist at the Massachusetts General Hospital and a collaborator on the study.


The study suggests complex ribozymes might have been important in the evolution of early life.


"We can get fairly complex enzymes more easily than we thought," Szostak said.


The findings were to be published in last Friday's issue of the journal Science.


Scientists have no direct way to study life forms that existed billions of years ago.


They study that world by trying to reconstruct molecules and to search for catalysts, like ribozymes, that might have been important.


The discovery of ribozymes in the early 1980s suggested there might be an "RNA world," a time before protein-based catalysts became the workhouses of biochemical reactions in modern cells and before deoxyribonucleic acid, or DNA, became the genetic code of life.


Ribozymes appear to fulfil two basic requirements as life's progenitor molecules: They contain the information to copy themselves and they can catalyze some reactions.


But little is known about the structure of ribozymes and the ancient world in which they existed. And few ribozymes have been identified.


"We hope to explore the range of reactions and the intrinsic properties of RNA," said David Bartel, principal author of the Science paper and a fellow at the Whitehead Institute.


The ability to generate such an efficient ribozyme from random sequences may hold promise for new ribozymes that could be used for diagnosing and treating diseases, the Whitehead Institute said.

Sign up for our free weekly newsletter

Our weekly newsletter contains a hand-picked selection of news, features, analysis and more from The Moscow Times. You will receive it in your mailbox every Friday. Never miss the latest news from Russia. Preview
Subscribers agree to the Privacy Policy

A Message from The Moscow Times:

Dear readers,

We are facing unprecedented challenges. Russia's Prosecutor General's Office has designated The Moscow Times as an "undesirable" organization, criminalizing our work and putting our staff at risk of prosecution. This follows our earlier unjust labeling as a "foreign agent."

These actions are direct attempts to silence independent journalism in Russia. The authorities claim our work "discredits the decisions of the Russian leadership." We see things differently: we strive to provide accurate, unbiased reporting on Russia.

We, the journalists of The Moscow Times, refuse to be silenced. But to continue our work, we need your help.

Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and every contribution makes a significant impact.

By supporting The Moscow Times, you're defending open, independent journalism in the face of repression. Thank you for standing with us.

Once
Monthly
Annual
Continue
paiment methods
Not ready to support today?
Remind me later.

Read more